🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christopher J. Fong

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0003-1628-3335
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.2Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4058
Top 20%
1.0DataRank
Top 20%23 citations

Renzo G. DiNatale, Phillip M. Rappold, Christopher J. Fong, Francisco Sánchez-Vega, Andrew W. Silagy +15 more

Papers

Driven by 14 papers — median percentile 59. Top paper: “Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma”.

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4058
Top 20%
1.0DataRank
Top 20%23 citations

Renzo G. DiNatale, Phillip M. Rappold, Christopher J. Fong, Francisco Sánchez-Vega, Andrew W. Silagy +15 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003
N/A
0.973DataRank · unranked
654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer

Nature Cancer(2022)10.1038/s43018-022-00416-8
N/A
0.888DataRank · unranked
372 citations

Jia Luo, Andrew Aukerman, Jacklynn V. Egger, Christopher J. Fong, Natally Horvat +16 more

Ovarian cancer mutational processes drive site-specific immune evasion

Nature(2022)10.1038/s41586-022-05496-1
N/A
0.863DataRank · unranked
314 citations

Florian Uhlitz, Nicholas Ceglia, Jamie Lim, Michelle Wu, Neeman Mohibullah +56 more

Shareable artificial intelligence to extract cancer outcomes from electronic health records for precision oncology research

Nature Communications(2024)10.1038/s41467-024-54071-x
N/A
0.724DataRank · unranked
21 citations

Justin Jee, Karl Pichotta, Megan Paul, Pavel Trukhanov, Christopher J. Fong +8 more

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors

Cancer Cell(2022)10.1016/j.ccell.2022.08.022
N/A
0.717DataRank · unranked
118 citations

Elio Adib, Sarah Abou Alaiwi, Talal El Zarif, Stefan Groha, Elie W. Akl +27 more

Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival

Nature Medicine(2025)10.1038/s41591-024-03362-3
N/A
0.659DataRank · unranked
80 citations

Maria Perry, Joanne F. Chou, Subhiksha Nandakumar, Daniel M. Muldoon, Amanda Erakky +24 more

A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response

Nature Communications(2020)10.1038/s41467-020-17965-0
N/A
0.631DataRank · unranked
66 citations

Kyrollis Attalla, Renzo G. DiNatale, Irina Ostrovnaya, Jessica Flynn, Kyle A. Blum +12 more

Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers

Cancer Cell(2023)10.1016/j.ccell.2023.10.003
N/A
0.542DataRank · unranked
36 citations

Dexter X. Jin, Justin Y. Newberg, Tomin Perea-Chamblee, Kelly R. Pekala, Christopher J. Fong +21 more

Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.005
N/A
0.312DataRank · unranked
7 citations

Tiffany Sia, Christopher J. Fong, Aliya Khurram, Michele Waters, Yelena Kemel +19 more

A health-system-scale, episode-resolved multimodal atlas of cancer cachexia

medRxiv(2025)10.1101/2025.09.29.25336906
Top 61%
0.241DataRank
Top 61%4 citations

Amy Xie, Sonia Boscenco, Ethan Tse, Neil Ruthen, Jamie Wang +12 more

Large-scale clinicogenomic models of solid tumor CNS metastasis.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2037
N/A
0DataRank · unranked
0 citations

Anisha Luthra, Christopher J. Fong, Karl Pichotta, Thinh Ngoc Tran, Mirella L. Altoé +15 more

Patterns of Metastatic Disease in Patients with Cancer Derived from Natural Language Processing of Structured CT Radiology Reports over a 10-year Period

Radiology(2021)10.1148/radiol.2021210043
N/A
0DataRank · unranked
54 citations

Kaelan Lupton, Pamela Causa Andrieu, Anisha Luthra, Michio Taya, Karen Batch +13 more

Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.08.016
N/A
0DataRank · unranked
1 citations

Sara Moufarrij, Juliet Milani, Sarah Kane, Qin Zhou, Christopher J. Fong +20 more